Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2013
Total Assets: $2.32B
Liabilities Breakdown FY2013
Total Liabilities: $962.6M
Asset Breakdown
Total Assets: $2.32B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $569.3M | 24.5% |
| Accounts Receivable | $85.5M | 3.7% |
| Inventory | $14.1M | 0.6% |
| Property, Plant & Equipment | $696.9M | 30.1% |
| Goodwill | $31.0M | 1.3% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $922.2M | 39.8% |
Liabilities Breakdown
Total Liabilities: $962.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $49.3M | 5.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $913.3M | 94.9% |